Clarifying the Spectrum of Driver Oncogene Mutations in Biomarker-Verified Squamous Carcinoma of Lung: Lack of <i>EGFR</i> / <i>KRA</i> S and Presence of <i>PIK3CA</i> / <i>AKT1</i> Mutations
Natasha Rekhtman(Memorial Sloan Kettering Cancer Center), Marc Ladanyi(Memorial Sloan Kettering Cancer Center), Mark G. Kris(Memorial Sloan Kettering Cancer Center), Laura J. Tafe(Dartmouth College), William D. Travis(Memorial Sloan Kettering Cancer Center), Geoffrey R. Oxnard(Foundation Medicine (United States)), Maria E. Arcila(Memorial Sloan Kettering Cancer Center), Paul K. Paik(Memorial Sloan Kettering Cancer Center), Maureen F. Zakowski(Memorial Sloan Kettering Cancer Center), André L. Moreira(NYU Langone Health)
Cited by 365
Related Papers
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k
OncoKB: A Precision Oncology Knowledge Base
|JCO Precision Oncology|2017|2.7k